Publication:
Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients

dc.contributor.coauthorBenning, Louise
dc.contributor.coauthorMorath, Christian
dc.contributor.coauthorBartenschlager, Marie
dc.contributor.coauthorReineke, Marvin
dc.contributor.coauthorToellner, Maximilian
dc.contributor.coauthorNusshag, Christian
dc.contributor.coauthorKaelble, Florian
dc.contributor.coauthorReichel, Paula
dc.contributor.coauthorSchaier, Matthias
dc.contributor.coauthorSchnitzler, Paul
dc.contributor.coauthorZeier, Martin
dc.contributor.coauthorBartenschlager, Ralf
dc.contributor.coauthorSpeer, Claudius
dc.contributor.kuauthorSüsal, Caner
dc.contributor.kuprofileFaculty Member
dc.contributor.researchcenterKoç University Transplant Immunology Research Centre of Excellence (TIREX)
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.yokid351800
dc.date.accessioned2024-11-09T23:06:05Z
dc.date.issued2022
dc.description.abstractN/A
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue3
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsorshipDietmar Hopp Stiftung [1DH2111111]
dc.description.sponsorshipRahel Goitein-Straus Program of the Heidelberg Faculty of Medicine
dc.description.sponsorshipstate of Baden-Wurttemberg
dc.description.sponsorshipGerman Federal Research Network Applied Surveillance and Testing within the Network University Medicine
dc.description.sponsorshipDKFZ@fightCOVID initiative
dc.description.sponsorshipHelmholtz Association's Initiative and Networking Fund Project "Virological and immunological determinants of COVID-19 pathogenesis -lessons to get prepared for future pandemics" [KA1Co-02]
dc.description.sponsorshipPhysician Scientist Program of the Heidelberg Faculty of Medicine Funding for this study has been received by the Dietmar Hopp Stiftung (grant number 1DH2111111). LB is funded by the Rahel Goitein-Straus Program of the Heidelberg Faculty of Medicine. RB is supported by the program for surveillance and control of SARS-CoV-2 mutations of the state of Baden-Wurttemberg, the German Federal Research Network Applied Surveillance and Testing within the Network University Medicine, the DKFZ@fightCOVID initiative, and the Helmholtz Association's Initiative and Networking Fund Project "Virological and immunological determinants of COVID-19 pathogenesis -lessons to get prepared for future pandemics (KA1Co-02 "COVIPA")." CS is funded by the Physician Scientist Program of the Heidelberg Faculty of Medicine. We thank Iris Arnold and Sabine Bonisch at the Department of Nephrology, Heeyoung Kim at the Department of Infectious Diseases, Molecular Virology, and Verena Backendorf at the Department of Immunology (all at Heidelberg University Hospital, Heidelberg, Germany) for their technical support.
dc.description.volume101
dc.identifier.doi10.1016/j.kint.2021.12.009
dc.identifier.eissn1523-1755
dc.identifier.issn0085-2538
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85124392001
dc.identifier.urihttp://dx.doi.org/10.1016/j.kint.2021.12.009
dc.identifier.urihttps://hdl.handle.net/20.500.14288/8915
dc.identifier.wos760943600004
dc.keywordsSARS-COV-2
dc.keywordsNeutralization
dc.keywordsBNT162B2
dc.keywordsKidney transplant
dc.languageEnglish
dc.publisherElsevier
dc.sourceKidney International
dc.subjectUrology
dc.subjectNephrology
dc.titleNatural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
dc.typeLetter
dspace.entity.typePublication
local.contributor.authorid0000-0003-2521-8201
local.contributor.kuauthorSüsal, Caner

Files